These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 12901837

  • 1. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
    Takahashi J, Fujigasaki H, Iwabuchi K, Bruni AC, Uchihara T, El Hachimi KH, Stevanin G, Dürr A, Lebre AS, Trottier Y, de Thé H, Tanaka J, Hauw JJ, Duyckaerts C, Brice A.
    Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
    [Abstract] [Full Text] [Related]

  • 2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
    Kumada S, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, Oda M.
    J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
    [Abstract] [Full Text] [Related]

  • 3. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content.
    Takahashi J, Fujigasaki H, Zander C, El Hachimi KH, Stevanin G, Dürr A, Lebre AS, Yvert G, Trottier Y, de Thé H, Hauw JJ, Duyckaerts C, Brice A.
    Brain; 2002 Jul; 125(Pt 7):1534-43. PubMed ID: 12077003
    [Abstract] [Full Text] [Related]

  • 4. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.
    Yamada M, Sato T, Shimohata T, Hayashi S, Igarashi S, Tsuji S, Takahashi H.
    Am J Pathol; 2001 Nov; 159(5):1785-95. PubMed ID: 11696439
    [Abstract] [Full Text] [Related]

  • 5. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
    Uchihara T, Fujigasaki H, Koyano S, Nakamura A, Yagishita S, Iwabuchi K.
    Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
    [Abstract] [Full Text] [Related]

  • 6. SUMOylation substrates in neuronal intranuclear inclusion disease.
    Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H.
    Neuropathol Appl Neurobiol; 2006 Feb; 32(1):92-100. PubMed ID: 16409557
    [Abstract] [Full Text] [Related]

  • 7. Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein.
    Woulfe J, Gray D, Prichett-Pejic W, Munoz DG, Chretien M.
    J Neuropathol Exp Neurol; 2004 Nov; 63(11):1200-7. PubMed ID: 15581187
    [Abstract] [Full Text] [Related]

  • 8. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
    McFadden K, Hamilton RL, Insalaco SJ, Lavine L, Al-Mateen M, Wang G, Wiley CA.
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
    [Abstract] [Full Text] [Related]

  • 9. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation.
    Morton AJ, Lagan MA, Skepper JN, Dunnett SB.
    J Neurocytol; 2000 Sep; 29(9):679-702. PubMed ID: 11353291
    [Abstract] [Full Text] [Related]

  • 10. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
    Qin Q, Inatome R, Hotta A, Kojima M, Yamamura H, Hirai H, Yoshizawa T, Tanaka H, Fukami K, Yanagi S.
    J Cell Biol; 2006 Feb 13; 172(4):497-504. PubMed ID: 16461359
    [Abstract] [Full Text] [Related]

  • 11. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H, Uchihara T, Koyano S, Iwabuchi K, Yagishita S, Makifuchi T, Nakamura A, Ishida K, Toru S, Hirai S, Ishikawa K, Tanabe T, Mizusawa H.
    Exp Neurol; 2000 Oct 13; 165(2):248-56. PubMed ID: 10993685
    [Abstract] [Full Text] [Related]

  • 12. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y, Higuchi K, Ohara S, Duyckaerts C, Hauw JJ, Uchihara T.
    J Neuropathol Exp Neurol; 2008 Apr 13; 67(4):299-308. PubMed ID: 18379438
    [Abstract] [Full Text] [Related]

  • 13. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
    Janer A, Martin E, Muriel MP, Latouche M, Fujigasaki H, Ruberg M, Brice A, Trottier Y, Sittler A.
    J Cell Biol; 2006 Jul 03; 174(1):65-76. PubMed ID: 16818720
    [Abstract] [Full Text] [Related]

  • 14. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
    Takahashi J, Tanaka J, Arai K, Funata N, Hattori T, Fukuda T, Fujigasaki H, Uchihara T.
    J Neuropathol Exp Neurol; 2001 Apr 03; 60(4):369-76. PubMed ID: 11305872
    [Abstract] [Full Text] [Related]

  • 15. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
    Dovey CL, Varadaraj A, Wyllie AH, Rich T.
    J Pathol; 2004 Aug 03; 203(4):877-83. PubMed ID: 15258989
    [Abstract] [Full Text] [Related]

  • 16. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH, Bazett-Jones DP.
    Biochem Cell Biol; 2002 Aug 03; 80(3):301-10. PubMed ID: 12123283
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L, Gao YS, Sztul E.
    Neurobiol Dis; 2005 Dec 03; 20(3):656-65. PubMed ID: 15964198
    [Abstract] [Full Text] [Related]

  • 18. Neuronal intranuclear hyaline inclusion disease.
    Takahashi-Fujigasaki J.
    Neuropathology; 2003 Dec 03; 23(4):351-9. PubMed ID: 14719553
    [Abstract] [Full Text] [Related]

  • 19. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y, Koppenhafer SL, Shoesmith SJ, Perez MK, Paulson HL.
    Hum Mol Genet; 1999 Apr 03; 8(4):673-82. PubMed ID: 10072437
    [Abstract] [Full Text] [Related]

  • 20. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.
    Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H.
    Neuroreport; 2002 Dec 03; 13(17):2359-64. PubMed ID: 12488827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.